Pretty much since we started this blog, we have written posts that essentially set forth the following mantra.
Our last post introduced how regulations around foreign investment in China’s hospitals are changing, with the most recent announcement of seven WFOE pilots as evidence of these changes. Experienced China watchers easily recognize what is happening: China has acknowledged that it has a problem which only foreign expertise and capital can fix.
China is in the midst of what at least appears to be a concerted government crackdown against foreign companies doing business in China.
In China, employment contracts for new employees often include a probation period (试用期) designed to give the employer (mostly) and the employee time to test each other out.
China Issues Multiple Final Rules and Proposals to Implement Recent Revisions to Its Core Medical Device Regulation
Throughout August 2014, the China Food and Drug Administration (CFDA or the Agency) made significant process in issuing finalized rules and guidances to implement the revisions to its core medical device regulation, the Medical Device Supervision and Administration Regulation (MDR) (see our alert, here).
Acquisitions of China assets by US companies have plummeted to their lowest level since 2002, according to recent data from Dealogic reported by the Wall Street Journal (“WSJ”) MoneyBeat blog.
Though it is Labor Day, it is also a Monday and on Monday mornings I like to map out what will likely be going on during the upcoming week both for me and for my law firm.
China joint ventures are notorious for their high failure rate. An old Chinese saying that is often applied to joint ventures is “same bed, different dreams.”